Cidara Therapeutics Inc. (CDTX)
NASDAQ: CDTX
· Real-Time Price · USD
22.50
-0.34 (-1.49%)
At close: Jun 16, 2025, 3:59 PM
21.27
-5.48%
After-hours: Jun 16, 2025, 04:58 PM EDT
-1.49% (1D)
| Bid | 21.13 |
| Market Cap | 291.82M |
| Revenue (ttm) | 302K |
| Net Income (ttm) | -180.73M |
| EPS (ttm) | -26.68 |
| PE Ratio (ttm) | -0.84 |
| Forward PE | -2.66 |
| Analyst | Strong Buy |
| Ask | 23.97 |
| Volume | 101,522 |
| Avg. Volume (20D) | 176,815 |
| Open | 23.04 |
| Previous Close | 22.84 |
| Day's Range | 22.45 - 23.43 |
| 52-Week Range | 10.14 - 28.42 |
| Beta | 0.80 |
About CDTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CDTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CDTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts6 months ago
+15.41%
Cidara Therapeutics shares are trading higher. The...
Unlock content with
Pro Subscription
1 month ago · seekingalpha.com
Cidara Therapeutics, Inc. (CDTX) Q1 2025 Earnings Call TranscriptCidara Therapeutics, Inc. (NASDAQ:CDTX ) Q1 2025 Earnings Conference Call May 8, 2025 5:00 PM ET Company Participants Brian Ritchie - LifeSci Advisors Jeffrey Stein - President and Chief Executive Off...
